2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid

C16H21N3O5S — CID 86736919

IUPAC2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid
SMILESCCOC(=O)C=C(C)NC(C(=O)O)c1ccc(O)c(CSC=NN)c1
InChIInChI=1S/C16H21N3O5S/c1-3-24-14(21)6-10(2)19-15(16(22)23)11-4-5-13(20)12(7-11)8-25-9-18-17/h4-7,9,15,19-20H,3,8,17H2,1-2H3,(H,22,23)
InChIKeyDOHXPERALKXUSC-UHFFFAOYSA-N
MW367.43 g/mol
LogP1.71
Rot. Bonds9

About 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid

2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid (PubChem CID 86736919) has the molecular formula C16H21N3O5S and a molecular weight of 367.43 g/mol. Its IUPAC name is 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid.

Molecular Properties

Compound Name2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid
PubChem CID86736919
Molecular FormulaC16H21N3O5S
Molecular Weight367.43 g/mol
Exact Mass367.12
IUPAC Name2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid
SMILESCCOC(=O)C=C(C)NC(C(=O)O)c1ccc(O)c(CSC=NN)c1
InChIInChI=1S/C16H21N3O5S/c1-3-24-14(21)6-10(2)19-15(16(22)23)11-4-5-13(20)12(7-11)8-25-9-18-17/h4-7,9,15,19-20H,3,8,17H2,1-2H3,(H,22,23)
InChIKeyDOHXPERALKXUSC-UHFFFAOYSA-N
XLogP1.71
TPSA134.24 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500367.43
LogP ≤ 51.71
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid?
The IUPAC name of 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid (CID 86736919) is 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid.
What is the SMILES notation for 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid?
The canonical SMILES for 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid is CCOC(=O)C=C(C)NC(C(=O)O)c1ccc(O)c(CSC=NN)c1.
What is the InChIKey of 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid?
The InChIKey is DOHXPERALKXUSC-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H21N3O5S/c1-3-24-14(21)6-10(2)19-15(16(22)23)11-4-5-13(20)12(7-11)8-25-9-18-17/h4-7,9,15,19-20H,3,8,17H2,1-2H3,(H,22,23).
What are the key properties of 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid?
2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid has a molecular weight of 367.43 g/mol, XLogP of 1.71, 9 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-2-[4-hydroxy-3-(methanehydrazonoylsulfanylmethyl)phenyl]acetic acid is sourced from PubChem (CID 86736919), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).